|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400090357 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-27 18:11:14 |
|
注册时间: Date of Registration: |
2024-09-27 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
跨模态信息驱动发作间期SEEG致痫区智能定位及疗效预测模型的构建 |
|
Public title: |
Construction of an Intelligent Localization and Efficacy Prediction Model for Seizure-Onset Zones in SEEG Driven by Cross-Modal Information during Interictal Periods |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
跨模态信息驱动发作间期SEEG致痫区智能定位及疗效预测模型的构建 |
|
Scientific title: |
Construction of an Intelligent Localization and Efficacy Prediction Model for Seizure-Onset Zones in SEEG Driven by Cross-Modal Information during Interictal Periods |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
黎思娴 |
研究负责人: |
黎思娴 |
|
Applicant: |
Sixian Li |
Study leader: |
Sixian Li |
|
申请注册联系人电话: Applicant telephone: |
+86 188 2342 8776 |
研究负责人电话: Study leader's telephone: |
+86 188 2342 8776 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
531888755@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
531888755@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
Shenzhen Second people's hospital |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
广东省深圳市福田区笋岗西路3002号深圳市第二人民医院 |
研究负责人通讯地址: |
广东省深圳市福田区笋岗西路3002号深圳市第二人民医院 |
|
Applicant address: |
Shenzhen Second People's Hospital, 3002 Sungang West Road, Futian District, Shenzhen City, Guangdong |
Study leader's address: |
Shenzhen Second People's Hospital, 3002 Sungang West Road, Futian District, Shenzhen City, Guangdong |
|
申请注册联系人邮政编码: Applicant postcode: |
518035 |
研究负责人邮政编码: Study leader's postcode: |
518035 |
|
申请人所在单位: |
深圳市第二人民医院 |
||
|
Applicant's institution: |
Shenzhen Second People's Hospital |
||
|
研究负责人所在单位: |
深圳市第二人民医院 |
||
|
Affiliation of the Leader: |
Shenzhen Second People's Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024-263-02PJ |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
深圳市第二人民医院临床科研伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Research Ethics Committee of Shenzhen Second People’s Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-09-20 00:00:00 |
||
|
伦理委员会联系人: |
钱文璟 |
||
|
Contact Name of the ethic committee: |
Wenjing Qian |
||
|
伦理委员会联系地址: |
广东省深圳市福田区笋岗西路2008号中成体育大厦707 |
||
|
Contact Address of the ethic committee: |
707 Zhongcheng Sports Building, No.2008 Sungang West Road, Futian District, Shenzhen City, Guangdong Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 755 8346 4301 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
lunli_707@163.com |
|
研究实施负责(组长)单位: |
深圳市第二人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shenzhen Second People’s Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广东省深圳市福田区笋岗西路3002号深圳市第二人民医院 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Shenzhen Second People's Hospital, 3002 Sungang West Road, Futian District, Shenzhen City, Guangdong Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-financing |
||||||||||||||||||||||
|
Target disease: |
Epilepsy |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
I期临床试验 | ||||||||||||||||||||||
|
Study phase: |
1 |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
基于发作间期SEEG融合多模态影像学数据,通过特征提取、结构-功能连接计算及各项参数贡献度分析等,实现EZ精准定位,并与临床案例结合,通过深度学习,不断优化和构建智能定位模型。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on interictal SEEG fused with multimodal imaging data, we achieve precise localization of epileptogenic zones (EZ) through feature extraction, structural-functional connectivity calculations, and parameter contribution analysis. By integrating this with clinical cases and utilizing deep learning, we continuously optimize and construct an intelligent localization model. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①入组时年龄为3岁及以上; ②确诊为局灶性癫痫(2017年国际抗癫痫联盟癫痫诊断及分类标准); ③经SEEG确定1处,且仅有1处致痫灶; ④已采取外科治疗(电极引导下热凝毁损术、病灶切除术); ⑤签署知情同意书。 ⑥未成年人需得到监护人同意。 |
||||||||||||||||||||||
|
Inclusion criteria |
①Age of 3 years or older at the time of enrollment; ②Diagnosed with focal epilepsy (according to the 2017 International League Against Epilepsy criteria for epilepsy diagnosis and classification);; ③Identified 1 epileptogenic zone via SEEG, and only 1 such zone; ④Surgical treatment has been performed (electrode-guided thermal coagulation or lesionectomy); ⑤Signed informed consent form. |
||||||||||||||||||||||
|
排除标准: |
①术中或术后出现严重并发症,如感染、出血; ②先天性或继发性颅脑结构不完整; ③严重精神疾病史; ④未控制的严重代谢性疾病; ⑤无法完成随访。 |
||||||||||||||||||||||
|
Exclusion criteria: |
①Severe complications during or after surgery, such as infection or bleeding; ②Congenital or secondary incomplete cranial structures; ③History of severe mental illness; ④Uncontrolled severe metabolic diseases; ⑤Unable to complete follow-up. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-10-01 00:00:00至 To 2026-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-10-01 00:00:00 至 To 2026-06-30 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
none |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
脑电图记录仪采集及保存数据;医院医学影像系统采集及保存数据 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The EEG recorder system collects and saves data; the hospital's medical imaging system collects and saves data. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |